Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-033016
Filing Date
2024-08-19
Accepted
2024-08-19 10:12:38
Documents
44
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 610378
2 ex31-1.htm EX-31.1 18748
3 ex31-2.htm EX-31.2 14995
4 ex32-1.htm EX-32.1 4619
5 ex32-2.htm EX-32.2 6936
  Complete submission text file 0001493152-24-033016.txt   3072230

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE btax-20240630.xsd EX-101.SCH 23087
7 XBRL CALCULATION FILE btax-20240630_cal.xml EX-101.CAL 30397
8 XBRL DEFINITION FILE btax-20240630_def.xml EX-101.DEF 63438
9 XBRL LABEL FILE btax-20240630_lab.xml EX-101.LAB 195298
10 XBRL PRESENTATION FILE btax-20240630_pre.xml EX-101.PRE 142828
47 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 436839
Mailing Address 2431 ALOMA AVE #124 WINTER PARK FL 32792
Business Address 2431 ALOMA AVE #124 WINTER PARK FL 32792 (888) 613-8802
Biostax Corp. (Filer) CIK: 0001559356 (see all company filings)

EIN.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54933 | Film No.: 241218632
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)